Metal Stents Market Size, Share, By Type [(Bare Metal Stents (BMS), Drug-Eluting Stents (DES), Grafted Stents, and Others)], Material [(Stainless Steel, Cobalt-Chromium Alloy, Platinum-Chromium Alloy, Nitinol (Nickel-Titanium Alloy), and Others)], Coating Material (Biodegradable, Durable Polymers, Polymer-Free, and Dual-Drug Coatings), Mechanism [(Balloon-Expandable, Self-Expanding, and Hybrid (Partially Self-Expanding)], Application (Coronary Stents, Peripheral Vascular Stents, Carotid Stents, Renal Artery Stents, Aortic Stents, and Others), End User (Hospitals, Cardiac Catheterization Labs, Outpatient Surgery Centers, and Others) and Region - Trends, Analysis, and Forecast till 2035

• By 2035, the metal stents market size is contemplated to enlarge at a valuation of USD 5.6 Billion.
• In 2024, the metal stents market valuation was USD 3.45 Billion.
• Metal stents market is developing at a CAGR of 4.6%.

Metal stents are small tube structures made of alloys such as stainless steel, cobalt-chromium or nitinol that are used to prop open the narrowed passageways or vessels. Although, most often used in coronary arteries, metal stents have also been shown to support bile ducts, esophagus and airways depending on clinical necessity. They can be found as bare metal, drug eluting, and covered (grafted) types and each type is used in special cases and with special considerations to the needs of the patient.

The rising rate of cardiovascular disease and cancerous conditions, which necessitate stenting in order to alleviate or cure the condition, is causing the metal stents market to expand. Minimally invasive stent procedures currently have faster recovery times, smaller complications, and overall improved patient outcomes over traditional surgery. Hybrid stents, which incorporate some features of both self-expanding and balloon-expandable stents, are allowing greater clinical use and leading to overall performance improvements.

In the future, metal stents will become more advanced. There is a research underway on bioabsorbable metal stent and smart ones fitted with sensors that can track in real time. The second-generation coating in drugs seeks to minimize the occurrence of complications such as restenosis and thrombosis. This category includes not only market colors of party that offer substantial business prospects but also emergent markets with increasing access to healthcare and the infrastructural development. Also, patient-specific stent designs around patient anatomy and their disease profiles are becoming a clinical reality.

Impact of Generative AI on Metal Stent Market:

•  Recent developments in artificial intelligence and its integration with medical imaging and modeling are having a positive impact on the metal stent market. For instance, an AI-Integrated intravascular imaging system utilizing an optical coherence tomography allows cardiologists to reconstruct arterial plaque structure in 3D, and predict stent positioning in real time, facilitating more accurate stent selection and positioning. Moreover, machine learning model trained to simulate the process of stent deployment when using braided stents can reproduce the best performance in milliseconds with up to 95% accuracy, improving procedural design and mitigating risks.

Key Drivers:

Rising Cardiovascular Disease Burden Drives Global Surge in Metal Stent Demand

The metal stent market is becoming bigger as there is an overwhelming prevalence of cardiovascular diseases in the world. Given the rising incidence of cardiovascular diseases including coronary artery disease, peripheral artery disease, and heart attacks due to the combination of aging population and sedentary lifestyles, unhealthy diets, and the growing rate of obesity, the availability of effective therapy alternatives such as metal stents has taken on increased importance.

Metal stents play a vital role in minimally invasive intervention in cardiology; they allow an obstructed arterial (blood) vessel to be removed and normal blood circulation restored, which enhances the life quality of the patient and increases life expectancy.

• For instance, in 2024, the American Heart Association has highlighted an increase in the prevalence of coronary artery disease in the U.S. attributed to lifestyle and an ageing population and this has also contributed to the demand of stent implantation processes. This increase in the cases is in direct proportion to increase in use of metal stents in hospitals and cardiac care units.

Restraints:

Smart Stents Face Early Challenges but Are Set to Improve Heart Care in the Future

Smart stents that contain sensors and wireless assimilations have potential to augment patient monitoring and allow personalized care. Nevertheless, challenges of the integration of these technologies, such as high development costs and a steep regulatory environment, especially in terms of cybersecurity, patient data privacy, and interoperability, are the major limitations. Such obstacles may delay product development and acceptance since manufacturers have to deal with not only new technologies, but also compliance to the existing rules regarding medical devices, which introduces uncertainty and risks into this innovative market.

• Counterbalance Statements: More healthcare providers are interested in precision medicine and remote patient management solutions, which promote collaboration between a medical device company and a digital technology company. Regulatory bodies are also adapting to more readily accept digital health elements through more efficient paths to approval of novel smart stents. Thus, in the long-term, enabled by digital technologies, the value and clinical usefulness of metal stents can improve, which brings new revenue opportunities and changes patient care.

Opportunities & Trends:

Next-Generation Alloy Stents Signal a Major Growth Trend in Minimally Invasive Cardiology

There is the increasing necessity in the implementation of stents, which are highly durable but still have increased biocompatibility, pose the lowest probability of complications (such as thrombosis), and can be dissolved or absorbed by the body after performing their operational cycle. Recent advances include work towards bioabsorbable metallic stents based on advanced magnesium or zinc alloys which present a clinical promise with reduced long term risk and enhanced vascular healing.

• For instance, A 2024 publication in the journal published by Springer materials science, reported the improved performance of the bioabsorbable magnesium-zinc alloy stents, which could exhibit their mechanical and biodegradation properties, molecular biocompatibility, and endogenous renal filtration. Existence of soft tissue without any aberrance of the implanted route as implanted in a porcine coronary artery indicated that implantation is benign to rising up the risk of this implantation over the limited term.

Type, material, coating material, mechanism, application, end user, and region are the divisions of the metal stents market.

ByType:

Bare metal stents, drug-eluting stents, grafted stents and others are the types on which metal stents market is segmented. Drug-Eluting stents are currently the dominant the metal stents market share and most widely used in the market. Drug-Eluting stents release medication over time to prevent restenosis the re-narrowing of arteries significantly reducing the need for repeat procedures and improving long-term vessel patency.

Second are bare metal stents as they remain widely used due to they are more cost-effective and simpler in design. They are often preferred in patients who have a high risk of bleeding or cannot tolerate prolonged use of dual antiplatelet therapy, which is commonly required with drug eluting stents.

By Material:

Stainless steel, cobalt-chromium alloy, platinum-chromium alloy, nitinol (nickel-titanium alloy), others are material of the metal stents market. Cobalt-Chromium alloys are dominant in modern stent design. They offer a good balance of strength, flexibility, and radiopacity (visibility under X-ray) which allows for thinner struts while maintaining performance.

The second most dominant material is stainless steel. Stainless steel stents have been widely used historically due to their durability and lower cost. Stainless steel remains significant especially in markets where cost sensitivity is high and in specific stent designs.

By Coating material:

Biodegradable, durable polymers, polymer-free, dual-drug coatings are the segments for coating material for metal stents market. Polymer-free coatings are preferred due to the minimize inflammation and promote faster healing by eliminating the adverse effects often associated with polymer use in traditional stents. This results in improved patient outcomes, particularly in cardiovascular treatments, and enhances medication delivery more efficiently while reducing complications such as late thrombosis.

The second-largest market is durable polymers. Durable polymers have been widely used historically in drug-eluting stents (DES) as carriers for drugs that prevent restenosis.Despite growing interest in biodegradable options, their proven efficacy maintains their dominance, particularly for long-term treatments.

By Mechanism:

The market for metal stents by mechanism can be segmented in balloon-expandable, self-expanding and hybrid. Balloon-expandable stents dominate 80% of the metal stents market share in 2025, valued for their precise deployment, radial strength, and adaptability across vessel sizes.

Self-expanding stents, the second most dominant type, grow steadily, due to their nitinol-based flexibility, ideal for peripheral and tortuous anatomies where constant vessel contact is critical.

By Application:

Coronary stents, peripheral vascular stents, carotid stents, renal artery stents, aortic stents, and others are application of the metal stents market. The coronary stents segment is the most prominent market, with the largest metal stents market shares. The prevalence of coronary artery disease (CAD) is high and continues to be the major cause of death throughout the world, which influences this dominance.  

The Peripheral Vascular Stents segment has the second highest market share These stents are used in treating a condition known as the peripheral artery disease (PAD), which affects the circulation to the body parts and other organs other than the heart.

By End Users:

The metal stents market on the account of end users are categorized into hospitals, cardiac catheterization labs, outpatient surgery centers, and others. Hospitals are the most dominant end-user segment in metal stents market share as hospitals have the ability to handle high-risk patients and post-procedural complications makes them the primary setting for stent implantations.

The second most dominant segment is represented by cardiac catheterization labs, especially for elective procedures. These specialized facilities provide focused expertise in stent placements, along with effective workflow optimization. Their increasing dominance mirrors the transition toward minimally invasive procedures and same-day interventions, as they offer a combination of advanced imaging capabilities and lower operational costs compared to full hospital settings.

Regional Insights:

Geographically, the metal stents market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This region leads metal stents market growth with 38.7% share as it has the advanced healthcare infrastructure, and fastest uptake of modern stent technology. The region has been at the forefront of clinical innovation, with the U.S. accounting close to half of the global stent-related patents and FDA-approved new stents typically years in advance of others. The prevalence of cardiovascular diseases and a developed reimbursement system are two reasons why both drug-eluting stents and bare-metal stents are widely used on the continent.

• U.S. Metal Stents Market Insights:

The U.S. is the market with the highest growth potential due to the promotion in stent technology which includes polymer-free drug-releasing stents and cobalt-chromium alloys. The 2022 FDA remedying of BIOTRONIKs Pulsar-18 T3 stent system augments this innovation, indeed, high quantities of minimally invasive cardiovascular operations enhancing the consumption of metal stents.

Asia Pacific: This is the fastest-growing regional market as is driven by the rising number of percutaneous coronary intervention procedures and augments of healthcare access. Most of this increase is happening in China and India, backed by local stent-manufacturing companies which now provide more than 70 percent of the stent requirements of this region. Government presence and efforts to advance cardiac care and the increased affordability of stent procedures are fueling market growth across emerging markets in the region.

• India Metal Stents Market Insights:

India is an exception in this region as it has shown a sharp increase in the cases of cardiovascular diseases due to change in lifestyle as well as due to the aging population. Healthcare infrastructure is developed very fast and people are getting more aware about heart health so there is a high demand of metal stents. According to research, by the United Nations Population Fund, India has the highest number of aged people whose number is expected to increase to almost half by 2050, supporting the growth of the Indian metal stent market in cardiovascular treatment.

Europe: This is the third-largest market of metal stents due to the extensive use of minimally invasive surgery, robust reimbursement models, and proactive efforts to incorporate cardiovascular programs. The markets in the region are increasingly making investments in drug-eluting and bioresorbable stent technology as local markets with sufficient domestic suppliers continue to grow. The growing trends of all these factors work in favor of the metal stents market in the region.

• Germany Metal Stents Market Insights:

Germany is the largest market in Europe, due to its well-developed healthcare system, high burden of cardiovascular disease, and strong research capacity. The nation does well in implementing the latest therapeutical interventions such as drug-eluting and biodegradable stents that have good regulatory standards that promote quality and performance. Solidly entrenched R&D ecosystem and an increased awareness initiatives make Germany one of the hotspots of innovative stent solutions.

Metal Stents Market Report Scope:

Attribute	Details
Market Size 2025	USD 3.8 Billion
Projected Market Size 2035	USD 5.6 Billion
CAGR Growth Rate	4.6% (2025-2035)
Base year for estimation	2024
Forecast period	2025 – 2035
Market representation	Revenue in USD Billion & CAGR from 2025 to 2035
Regional scope	North America - U.S. and Canada Europe – Germany, U.K., France, Russia, Italy, Spain, Netherlands, and Rest of Europe Asia Pacific – China, India, Japan, Australia, Indonesia, Malaysia, South Korea, and Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, and Rest of Latin America Middle East & Africa – GCC, Israel, South Africa, and Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segmentation:

By Type:

• Bare Metal Stents (BMS)
• Drug-Eluting Stents (DES)
• Grafted Stents
• Others

By Material:

• Stainless Steel
• Cobalt-Chromium Alloy
• Platinum-Chromium Alloy
• Nitinol (Nickel-Titanium Alloy)
• Others

By Coating material:

• Biodegradable
• Durable Polymers
• Polymer-Free
• Dual-Drug Coatings

By Mechanism:

• Balloon-Expandable
• Self-Expanding
• Hybrid

By Application:

• Coronary Stents
• Peripheral Vascular Stents
• Carotid Stents
• Renal Artery Stents
• Aortic Stents
• Others

By End Users:

• Hospitals
• Cardiac Catheterization Labs
• Outpatient Surgery Centers
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Some of the strategies through which companies can promote the growth of the metal stent market include investing in research and development of bioabsorbable and drug-eluting stents, targeting the emerging markets, where the cases of cardiovascular diseases are on the increase and strategic alliances with other hospitals and research centers. Increasing regulatory compliance and having large-scale clinical trials will help the approval process faster and physician assurance. The key players operating in the metal stents market include, Abbott, Cook, MicroPort Scientific Corporation, Meril Life Sciences, SCITECH, B. Braun SE, , Johnson & Johnson, Terumo Europe NV, Boston Scientific Corporation.

Metal Stents Market Companies:

• Abbott
• optimed Medical Instruments GmbH
• ELLA – CS, s.r.o
• Eurocor Tech GmbH
• Alvimedica
• Cook
• MicroPort Scientific Corporation
• Meril Life Sciences
• SCITECH
• B. Braun SE
• Lepu Medical Technology (Beijing) Co.,Ltd.
• MICRO-TECH (Nanjing) Co., Ltd.
• Johnson & Johnson
• Terumo Europe NV
• Boston Scientific Corporation

View an Additional List of Companies in the Metal Stents Market

• In 2024, scientists at the Korea Institute of Science and Technology (KIST) designed a method of laser patterning generating nano- and micro-wrinkles on nickel-titanium alloy stents, radically enhancing vascular healing. The surface technology boosted endothelial cell growth by 250 percent and suppress smooth muscle proliferation by three-fourths, which was a significant disadvantage of drug-eluting stents including delayed healing and risk of thrombosis.
• In 2022, A team at the IMDEA Materials Institute has been able to advance in the development of zinc alloy biodegradable stents that dissolve on their own after sustaining vessels thereby limiting the inherent risk of developing blood clots, vessel stenosis, and chronic inflammation. Clinical trials of magnesium-based bioresorbable stents have been demonstrated to be safe and maintain long-term patency.

Analyst View:

The growth of the market of metal stents is attributed to the increasing population of cardiovascular diseases, aged population and the change of lifestyles. Such stents play an important part in sustaining arterial patency and disease conditions such as coronary and peripheral artery disease. Advances in stent technology include thinner designs, bioresorbable-coatings, which assist in the enhancement of clinical performance and patient safety. Growth is being driven by the healthcare infrastructure in emerging economies and by the expansion in minimally invasive operations.

More Related Reports

Automotive Metal Casting Market
Metal 3D Printer Market
Metal Gasket Market
India Metal Fabrication Equipment Market
Metal Forming Tools Market

Company Name	SCITECH
Headquarter	Goias, Brazil
CEO	Marco Costa
Employee Count	178 Employees